© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
July 20, 2020
A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.
July 15, 2020
The practice of genetic testing has been useful in clinically addressing found cases of familial hypercholesterolemia, among other conditions, but no clinical practice guidelines currently exist for testing patients with suspected hereditary dyslipidemia.
June 23, 2020
While often referred to as "Good cholesterol" new research suggests HDL measurements do little for predicting risk of heart attack in Black patients
June 17, 2020
Discussing how advances in care and therapeutic agents have impacted the management of diabetes in 2020.
June 13, 2020
Deepak Bhatt, MD, MPH, discusses the results of the latest REDUCE-IT analysis, titled REDUCE-IT DIABETES, presented at ADA 2020.
June 09, 2020
A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.
June 08, 2020
A new analysis examines impact of treatment adherence in more than 1.2 million patients.
June 01, 2020
The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.
May 29, 2020
Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.
May 28, 2020
The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients.